statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) PR Newswire SOUTH SAN FRANCISCO, Calif., July 12, 2024...

Rigel Announces Reverse Stock Split

Rigel Announces Reverse Stock Split Rigel Announces Reverse Stock Split PR Newswire SOUTH SAN FRANCISCO, Calif., June 25, 2024 SOUTH SAN FRANCISCO, Calif., June 25, 2024 /PRNewswire/ -- Rigel...

Rigel Pharmaceuticals Completes Transfer of GAVRETO (pralsetinib) New Drug Application

Rigel Pharmaceuticals Completes Transfer of GAVRETO (pralsetinib) New Drug Application Rigel Pharmaceuticals Completes Transfer of GAVRETO (pralsetinib) New Drug Application PR Newswire SOUTH SAN...

Rigel Announces Five Presentations at the EHA2024 Hybrid Congress

Rigel Announces Five Presentations at the EHA2024 Hybrid Congress Rigel Announces Five Presentations at the EHA2024 Hybrid Congress PR Newswire SOUTH SAN FRANCISCO, Calif., June 14, 2024 - Oral...

Rigel Highlights New Data in Three Poster Presentations at the 2024 ASCO Annual Meeting

Rigel Highlights New Data in Three Poster Presentations at the 2024 ASCO Annual Meeting Rigel Highlights New Data in Three Poster Presentations at the 2024 ASCO Annual Meeting PR Newswire SOUTH SAN...

Rigel to Present at the Jefferies Global Healthcare Conference

Rigel to Present at the Jefferies Global Healthcare Conference Rigel to Present at the Jefferies Global Healthcare Conference PR Newswire SOUTH SAN FRANCISCO, Calif., May 30, 2024 SOUTH SAN...

Rigel Announces Presentations at the Upcoming 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress

Rigel Announces Presentations at the Upcoming 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress Rigel Announces Presentations at the Upcoming 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress...

Rigel Reports First Quarter 2024 Financial Results and Provides Business Update

Rigel Reports First Quarter 2024 Financial Results and Provides Business Update Rigel Reports First Quarter 2024 Financial Results and Provides Business Update PR Newswire SOUTH SAN FRANCISCO...

Rigel Announces Conference Call and Webcast to Report First Quarter 2024 Financial Results and Business Update

Rigel Announces Conference Call and Webcast to Report First Quarter 2024 Financial Results and Business Update Rigel Announces Conference Call and Webcast to Report First Quarter 2024 Financial...

Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) PR Newswire SOUTH SAN FRANCISCO, Calif., April 10, 2024...

Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology. The firm focuses on intracellular signalling pathways and related targets that are critical to disease mechanisms. The company's products include Tavalisse, Fostamatinib and R835. Rigel Pharmaceuticals was founded by Donald G. Payan, James M. Gower, Thomas A. Raffin, Garry P. Nolan and Ronald B. Garren on June 14, 1996 and is headquartered in South San Francisco, CA.

Volume	59,572.00
52-Wk High	$17.30
52-Wk Low	$7.12

RIGL Rigel Pharmaceuticals

About

Feed

News

Sentiment

Earnings

Fundamentals